Redefining clinical trials: Adopting AI for speed, volume and diversity
IBM Big Data Hub
MAY 6, 2024
Learning from historical protocol data and using synthetically generated scenario events to optimize inclusion and exclusion criteria can be powerful for achieving efficient trial design. IBM is at the forefront of adopting AI for the pharmaceutical business, showcasing our commitment to refining this domain.
Let's personalize your content